contractor articles (622)
Active Articles:
A50691: Apligraf®A52438: Billing and Coding: Tetanus Immunization
A52527: Self-Administered Drug Exclusion List: and Biologicals Excluded from Coverage - Medical Policy Article (R7) (A52527)
A52537: Traumeel Injections
A54137: Response to Comments: Intravenous Immune Globulin (IVIG) L35893
A54139: Response to Comments: Somatosensory Testing L35906
A54141: Response to Comments: Infectious Disease Molecular Diagnostic Testing L35878
A54159: Response to Comments: Nerve Conduction Studies and Electromyography
A54187: Billing and Coding: MolDX: Avise PG Assay
A54201: Billing and Coding: MolDX: Vectra™ DA
A54241: Billing and Coding: MolDX: 4q25-AF Risk Genotype Guidelines
A54243: Billing and Coding: MolDX: CHD7 Gene Analysis Guidelines
A54253: Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency(ASPA) Testing
A54255: Billing and Coding: MolDX: BCKDHB Gene Test
A54256: Billing and Coding: MolDX: BLM Gene Analysis
A54257: Billing and Coding: MolDX: BluePrint® Test
A54262: Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests
A54263: Billing and Coding: MolDX: FANCC Genetic Testing
A54271: Billing and Coding: MolDX: Immunohistochemistry (IHC) Indications for Breast Pathology
A54274: Billing and Coding: MolDX: L1CAM Gene Sequencing Guidelines
A54277: Billing and Coding: MolDX: MCOLN1 Genetic Testing Guidelines
A54285: Billing and Coding: MolDX: SMPD1 Genetic Testing
A54288: Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests Guidelines
A54291: Billing and Coding: MolDX: NSD1 Gene Tests
A54327: Billing and Coding: ArgusM II Retinal Prosthesis System
A54584: Response to Comments: Molecular Diagnostic Tests(MDTs) L36021
A54586: Response to Comments: Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II prothrombin, and MTHFR)
A54588: Response to Comments: MoPath: Special Histochemical Stains and Immunohistochemical Stains
A54607: Response to Comments: MolDx: MGMT Promoter Methylation Analysis DL36113
A54610: Response to Comments for MolDX: Biomarkers in Cardiovascular Risk Assessment
A54611: Response to Comments for MolDX: Breast Cancer Assay: Prosigna
A54612: Response to Comments for MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A54613: Response to Comments for MolDX: Genomic Health™ Oncotype DX® Prostate Cancer Assay
A54614: Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing
A54616: Response to Comments: Prolaris Prostate Cancer Genomic Assay
A54617: Response to Comments: Molecular RBC Phenotyping
A54619: Response to Comments: MolDX: ConfirMDX Epigentic Molecular Assay
A54689: Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx®
A54777: Response to Comments: Bone Mass Measurement
A54780: Response to Comments: MolDX: Chromosome 1p/19q Deletion Analysis
A54781: Response to Comments: Minimally-Invasive Surgical (MIS) Fusion of Sacroiliac (SI) Joint
A54790: Response to Comments: MolDX: Breast Cancer Assay: Prosigna
A54791: Response to Comments: Repetitive Transcranial magnetic Stimulation (rTMS) in Adults with Treatment Resistant Major Depression Disorder
A54813: Response to Comments: MolDX: HLA-DQB1 0602 Testing for Narcolepsy
A54814: Response to Comments: MolDX: BRCA1 and BRCA2 Genetic Testing
A54830: Billing and Coding: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268)
A54881: Response to Comments: MolDX: HLA-B*15:02 Genetic Testing
A54899: Response to Comments: MolDX Biomarkers in Cardiovascular Risk Assessment
A54983: Response to Comments: MolDX-CDD: Genomic Health™ Oncotype DX® Prostate Cancer Assay
A54988: Response to Comments: MolDX Biomarkers in Cardiovascular Risk Assessment
A55276: Response to Comments: Wound Application of Cellular and/or Tissue Based products (CTPs), Lower Extremities
A55305: Response to Comments: MolDX- CDD: ProMark Risk
A55306: Response to Comments: MolDX-CDD: Decipher® Prostate Cancer Classifier Assay
A55313: Response to Comments: Proton Beam Therapy
A55427: Response to Comments: GlycoMark Testing for Glycemic Control
A55429: Response to Comments: Bladder Tumor Markers
A55430: Response to Comments: Polysomnography and Other Sleep Studies
A55431: Response to Comments: Circulating Tumor Cell Marker Assays
A55432: Response to Comments: Nerve Conduction Studies and Electromyography
A55435: Response to Comments: MolDX: HLA-DQB1*06:02
A55436: Response to Comments: MolDX - CDD: Oncotype DX ® Breast Cancer for DCIS (Genomic Health ™)
A55444: Response to Comments: 4K Score Assay
A55451: Response to Comments: Bladder/Urothelial Tumor
A55452: Response to Comments: MolDX: APC and MUTYH Gene
A55453: Response to Comments: MolDX-CDD: Percepta©
A55560: Response to Comments: Coenzyme Q10 (CoQ10)
A55561: Response to Comments: MolDX DecisionDX Uveal
A55562: Response to Comments: MolDX: Xpresys Lung
A55564: Response to Comments: MolDX: VitaRisk ™ Pharmacogenetic Test for Dry Age-related Macular Degeneration (AMD)
A55566: Response to Comments: MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease
A55716: Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML)
A55736: Response to Comments: MolDX: Prometheus IBD sgi Diagnostic Policy
A55737: Response to Comments: Chiropractic Service DL37524
A55875: Response to Comments: MolDX: AlloSure® Donor-Derived Cell-Free DNA Test
A55876: Response to Comments: MolDX: EndoPredict Breast Cancer Gene Expression Test
A56142: Response to Comments: MolDX: Corus® CAD Assay
A56148: Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
A56161: Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels
A56177: Response to Comments: MolDX: Cystatin C Measurement
A56190: Response to Comments: MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs)
A56239: Response to Comments: Frequency of Hemodialysis DL37575
A56283: Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test
A56313: Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
A56330: Response to Comments: MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Very Low and Low Risk Disease
A56345: Billing and Coding: MolDX: Oncotype DX® Genomic Prostate Score
A56354: Response to Comments: MolDX: MDS FISH
A56366: Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
A56374: Response to Comments: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
A56427: Response to Comments: MolDX: myPath Melanoma Assay
A56448: Billing and Coding: Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography
A56453: Billing and Coding: Cataract Extraction
A56456: Billing and Coding: Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy
A56459: Billing and Coding: Debridement Services
A56461: Billing and Coding: Endoscopy by Capsule
A56462: Billing and Coding: Erythropoiesis Stimulating Agents (ESA)
A56463: Billing and Coding: Facet Joint Injections, Medial Branch Blocks, and Facet Joint Radiofrequency Neurotomy
A56469: Billing and Coding: Lumbar Epidural Steroid Injections (ESI)
A56496: Response to Comments: MolDX DecisionDx-Melanoma
A56535: Billing and Coding: Minimally-Invasive Surgical (MIS) Fusion of the Sacroiliac (SI) Joint
A56696: Billing and Coding: Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities
A56779: Billing and Coding: Intravenous Immune Globulin
A56798: Billing and Coding: Vitamin D Assay Testing
A56799: Billing and Coding: Billing and Coding for Visual Fields Testing
A56816: Billing and Coding: Computerized Corneal Topography
A56818: Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing
A56828: Billing and Coding: MolDX: APC and MUTYH Gene
A56836: Billing and Coding: Mohs Micrographic Surgery
A56881: Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
A56882: Billing and Coding: MolDX: Genetic Testing for Lynch Syndrome
A56884: Billing and Coding: MolDX: Breast Cancer Index™ (BCI) Gene Expression Test
A56947: Billing and Coding: MolDX: BDX-XL2
A56951: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
A56971: Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing
A56972: Billing and Coding: MolDX: Percepta® Bronchial Genomic Classifier
A56973: Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)
A56985: Billing and Coding: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
A56988: Billing and Coding: MolDX: Cystatin C Measurement
A56997: Billing and Coding: MolDX: EndoPredict Breast Cancer Gene Expression Test
A57038: Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based
A57039: Billing and Coding: Stretta Procedure
A57040: Billing and Coding: Speech-Language Pathology
A57041: Billing and Coding: Somatosensory Testing
A57043: Billing and Coding: RAST Type Tests
A57044: Billing and Coding: Removal of Benign Skin Lesions
A57047: Billing and Coding: Repetitive Transcranial Magnetic Stimulation (rTMS) in Adults with Treatment Resistant Major Depressive Disorder
A57049: Billing and Coding: Polysomnography and Other Sleep Studies
A57050: Billing and Coding: Post-Void Residual Urine and/or Bladder Capacity by Ultrasound
A57052: Billing and Coding: Psychiatric Inpatient Hospitalization
A57053: Billing and Coding: Psychiatric Partial Hospitalization Programs
A57065: Billing and Coding: Outpatient Psychiatry and Psychology Services
A57067: Billing and Coding: Outpatient Physical and Occupational Therapy Services
A57069: Billing and Coding: Ophthalmic Angiography (Fluorescein and Indocyanine Green)
A57070: Billing and Coding: Ophthalmic Biometry for Intraocular Lens Power Calculation
A57071: Billing and Coding: Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
A57132: Billing and Coding: Bone Mass Measurement
A57141: Billing and Coding: MolDX: Repeat Germline Testing
A57149: Billing and Coding: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea
A57160: Billing and Coding: Immune Thrombocytopenia (ITP) Therapy
A57165: Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing
A57167: Billing and Coding: MolDX: AlloSure® or Equivalent Cell-Free DNA Testing for Kidney and Heart Allografts
A57193: Billing and Coding: Routine Foot Care and Debridement of Nails
A57282: Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
A57285: Response to Comments: Micro Invasive Glaucome Surgery (MIGS)
A57305: Billing and Coding: Varicose Veins of the Lower Extremity, Treatment of
A57306: Billing and Coding: Transthoracic Echocardiography (TTE)
A57307: Billing and Coding: Nerve Conduction Studies and Electromyography
A57446: Billing and Coding: MolDX: TruGraf Blood Gene Expression Test
A57454: Response to Comments: MolDX: TruGraf Blood Gene Expression Test
A57663: Billing and Coding: Nerve Blocks for Peripheral Neuropathy
A57795: Response to Comments: MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Intermediate Risk Disease
A57859: Billing and Coding: MolDX: Prospera™
A57860: Response to Comments: MolDX: Prospera™
A57870: Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors
A57873: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57876: Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors
A57877: Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57910: Billing and Coding: MolDX: Testing of Multiple Genes
A57915: Billing and Coding: MolDX: Pigmented Lesion Assay
A57916: Response to Comments: MolDX: Pigmented Lesion Assay
A57917: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A57918: Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A57926: Billing and Coding: Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
A57927: Response to Comments: Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
A57929: Response to Comments: Immune Thrombocytopenia (ITP) Therapy
A57930: Response to Comments: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
A58038: Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
A58039: Response to Comments: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
A58040: Response to Comments: MolDX: Repeat Germline Testing
A58113: Off-Label Use of Drugs and Biologicals for Anti-Cancer Chemotherapeutic Regimen
A58127: Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM)
A58178: Response to Comments: MolDX: Pharmacogenomics Testing
A58218: Billing and Coding: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58270: Response to Comments: Vitamin D Assay Testing
A58330: Billing and Coding: MolDX: Minimal Residual Disease Testing for Colorectal Cancer
A58331: Response to Comments: MolDX: Signatera and Minimal Residual Disease Testing for Colorectal Cancer
A58368: Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A58382: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)
A58398: Response to Comments: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58452: Response to Comments: MolDX: Blood Product Molecular Antigen Typing
A58463: Response to Comments: Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
A58479: Response to Comments: MolDX: AlloSure® or Equivalent Cell-Free DNA Testing for Kidney and Heart Allografts
A58480: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A58526: Billing and Coding: Complex Drug Administration Coding